biotech
biotech Articles
Proteostasis Therapeutics saw its shares slide early on Thursday after the company reported positive data from its early stage trial in cystic fibrosis.
Published:
Last Updated:
Axovant Sciences shares more than doubled on Wednesday after the company announced a new licensing agreement.
Published:
Last Updated:
The 54th annual meeting of the American Society of Clinical Oncology (ASCO) has just concluded and there were some significant moves we saw as a result.
Published:
Last Updated:
Mylan saw its shares make a handy gain early on Tuesday after the FDA announced a key approval for Fulphila (pegfilgrastim-jmbd), a biosimilar to Neulasta (pegfilgrastim).
Published:
Last Updated:
Jounce Therapeutics watched its shares drop sharply on Monday after the company presented preliminary data from its early stage cancer trial at the 2018 American Society of Clinical Oncology (ASCO)...
Published:
Last Updated:
Nektar Therapeutics (NASDAQ: NKTR) saw its shares get nearly halved in Monday’s session after the company released preliminary data from its early stage cancer study. The preliminary results...
Published:
Last Updated:
Clearside Biomedical shares were dropping early on Thursday after the company released data from its midstage clinical trial of Eylea for diabetic macular edema.
Published:
Last Updated:
vTv Therapeutics watched its shares make a massive gain early on Thursday after the firm announced an exclusive licensing agreement with Newsoara Biopharma.
Published:
Last Updated:
CRISPR Therapeutics shares saw a significant drop on Thursday morning after an announcement that the FDA placed a clinical hold on the Investigational New Drug Application (IND) for CTX001 for the...
Published:
Last Updated:
Immutep shares saw a nice gain in Wednesday’s session after the company released new data from its early-stage clinical trial in unresectable or metastatic melanoma patients.
Published:
Last Updated:
The May 15 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
Published:
Last Updated:
Melinta Therapeutics saw its shares plunge on Thursday after the firm announced that it had priced a secondary offering.
Published:
Last Updated:
Cara Therapeutics shares made a solid gain on Wednesday after the firm announced that it has licensed rights to commercialize Korsuva injection for the treatment of chronic kidney disease-associated...
Published:
Last Updated:
Esperion Therapeutics shares were halted in premarket trading on Wednesday after the firm announced late-stage trial results for its cholesterol drug.
Published:
Last Updated:
Amgen shares made a slight gain on Tuesday after it was announced that the FDA approved its treatment of glucocorticoid-induced osteoporosis in men and women at high risk of fracture.
Published:
Last Updated: